10.03
price down icon0.20%   -0.02
after-market Dopo l'orario di chiusura: 10.03
loading
Precedente Chiudi:
$10.05
Aprire:
$9.9
Volume 24 ore:
159.84K
Relative Volume:
0.90
Capitalizzazione di mercato:
$354.02M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.86%
1M Prestazione:
+0.00%
6M Prestazione:
-51.03%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$9.37
$10.33
Intervallo di 1 settimana:
Value
$9.15
$11.07
Portata 52W:
Value
$7.13
$29.74

Rapport Therapeutics Inc Stock (RAPP) Company Profile

Name
Nome
Rapport Therapeutics Inc
Name
Telefono
857-321-8020
Name
Indirizzo
1325 BOYLSTON STREET, BOSTON
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
RAPP's Discussions on Twitter

Confronta RAPP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RAPP
Rapport Therapeutics Inc
10.03 354.02M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-02 Iniziato Jefferies Buy
2024-07-02 Iniziato Stifel Buy
2024-07-02 Iniziato TD Cowen Buy

Rapport Therapeutics Inc Borsa (RAPP) Ultime notizie

pulisher
04:33 AM

Rapport Therapeutics: Too Early To Be Interesting (NASDAQ:RAPP) - Seeking Alpha

04:33 AM
pulisher
03:34 AM

Swiss National Bank Purchases New Stake in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

03:34 AM
pulisher
Mar 27, 2025

Analyzing Neurogene (NASDAQ:NGNE) & Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

(RAPP) Long Term Investment Analysis - news.stocktradersdaily.com

Mar 26, 2025
pulisher
Mar 26, 2025

Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 26, 2025
pulisher
Mar 23, 2025

Vanda Pharmaceuticals (NASDAQ:VNDA) and Rapport Therapeutics (NASDAQ:RAPP) Financial Contrast - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

Rapport Therapeutics to present data at 2025 AAN meeting - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting - GlobeNewswire

Mar 21, 2025
pulisher
Mar 21, 2025

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting - GlobeNewswire Inc.

Mar 21, 2025
pulisher
Mar 15, 2025

Several Insiders Invested In Rapport Therapeutics Flagging Positive News - Simply Wall St

Mar 15, 2025
pulisher
Mar 15, 2025

Positive Signs As Multiple Insiders Buy Rapport Therapeutics Stock - Yahoo Canada Finance

Mar 15, 2025
pulisher
Mar 15, 2025

Insider Buying: Rapport Therapeutics Chief Financial Officer Bought US$101k Of Shares - Yahoo Finance

Mar 15, 2025
pulisher
Mar 13, 2025

Rapport Therapeutics CFO Troy Ignelzi buys $100,988 in stock - Investing.com

Mar 13, 2025
pulisher
Mar 13, 2025

Rapport Therapeutics director Wendy Young acquires $61,249 in stock - Investing.com India

Mar 13, 2025
pulisher
Mar 13, 2025

Rapport Therapeutics Executives Acquire Shares - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

Rapport Therapeutics CFO Troy Ignelzi buys $100,988 in stock By Investing.com - Investing.com UK

Mar 13, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics Reports Q4 Net Loss Of $19.98 Mln - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics reports Q4 EPS (57c) vs. ($8.01) last year - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Rapport Therapeutics Inc Q4 Net Loss $20.0 Million -March 11, 2025 at 07:20 am EDT - Marketscreener.com

Mar 11, 2025
pulisher
Mar 11, 2025

Rhumbline Advisers Has $182,000 Stock Position in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

New York State Common Retirement Fund Acquires New Position in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 07, 2025
pulisher
Mar 05, 2025

(RAPP) On The My Stocks Page - Stock Traders Daily

Mar 05, 2025
pulisher
Mar 04, 2025

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development - BioSpace

Mar 04, 2025
pulisher
Mar 03, 2025

Rapport Therapeutics appoints new chief medical officer By Investing.com - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

Rapport Therapeutics, Inc. Announces Appointment of Jeffrey Sevigny as Chief Medical Officer - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Rapport Therapeutics appoints new chief medical officer - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

Rapport Therapeutics Announces Appointment of Dr. Jeffrey - GlobeNewswire

Mar 03, 2025
pulisher
Feb 24, 2025

Rapport Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Feb 24, 2025
pulisher
Feb 22, 2025

Rapport Therapeutics (RAPP) Expected to Announce Earnings on Thursday - Defense World

Feb 22, 2025
pulisher
Feb 20, 2025

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 8.5%Here's What Happened - MarketBeat

Feb 20, 2025
pulisher
Feb 13, 2025

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap UpHere's Why - MarketBeat

Feb 13, 2025
pulisher
Feb 12, 2025

How To Trade (RAPP) - Stock Traders Daily

Feb 12, 2025
pulisher
Feb 11, 2025

Rapport Therapeutics (NASDAQ:RAPP) Shares Down 5.6%What's Next? - MarketBeat

Feb 11, 2025
pulisher
Feb 10, 2025

Jennison Associates LLC Acquires Shares of 62,287 Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Feb 10, 2025
pulisher
Feb 05, 2025

Rapport Therapeutics (NASDAQ:RAPP) Short Interest Down 15.3% in January - MarketBeat

Feb 05, 2025
pulisher
Feb 04, 2025

JPMorgan Chase & Co. Purchases Shares of 4,033 Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Feb 04, 2025
pulisher
Feb 03, 2025

Rapport Therapeutics (NASDAQ:RAPP) Trading Up 4.6%Here's What Happened - MarketBeat

Feb 03, 2025
pulisher
Feb 02, 2025

J&J-backed Rapport Therapeutics files for $100M IPO - MSN

Feb 02, 2025
pulisher
Feb 01, 2025

Rapport Therapeutics (RAPP) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

Feb 01, 2025
pulisher
Jan 31, 2025

(RAPP) Proactive Strategies - Stock Traders Daily

Jan 31, 2025
pulisher
Jan 31, 2025

Rapport Therapeutics (RAPP) Projected to Post Quarterly Earnings on Thursday - Defense World

Jan 31, 2025
pulisher
Jan 24, 2025

‘A really rational IPO environment’: What does it takes for a biotech to go public now? - Fierce Biotech

Jan 24, 2025
pulisher
Jan 21, 2025

Barclays PLC Increases Stock Holdings in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Jan 21, 2025

Rapport Therapeutics Inc Azioni (RAPP) Dati Finanziari

Non sono disponibili dati finanziari per Rapport Therapeutics Inc (RAPP). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Capitalizzazione:     |  Volume (24 ore):